Skip to main content
. Author manuscript; available in PMC: 2022 Jan 29.
Published in final edited form as: Clin Cancer Res. 2019 Dec 23;26(6):1486–1496. doi: 10.1158/1078-0432.CCR-19-2478

Figure 1.

Figure 1.

Everolimus inhibited invasion of 3D-spheroids formed by DCIS cells, MCF-10DCIS.COM or SUM225, through Matrigel. A. Representative Images were acquired with a 20× objective showing invasive extensions from the 3D-spheroids in the control group, but not in the everolimus treatment groups. B. The invasive percentage was calculated by No. of invasive 3D-organoid / No. of total 3D-organoid X 100. Data are shown as means ± SEM, n=3. **p<0.01 vs Vehicle control group with one-way ANOVA.